Professor Arne Astrup, MD, DMSc. was Senior Vice President at The Novo Nordisk Foundation in Denmark, and leader of the Dept of Obesity and Nutritional Sciences from 2020 until August 1st, 2025. Since then, he has been an independent consultant and board member in a number of international companies, in addition to be appointed by the Novo Nordisk Foundation to represent the foundation in Centre for Healthy Childhood, Denmark. Arne Astrup has been a full professor since 1990 and Head of the Department of Nutrition, Exercise and Sports, University of Copenhagen, from 2012-20. Under Arne Astrup’s leadership the Department of Nutrition, Exercise and Sports ranked number one in the internationally recognized Shanghai Ranking of Global Ranking of Sport Science Schools and Departments. Dr Astrup is past President of World Obesity Federation and founding editor-in-chief of Obesity Reviews. He is Associate Editor of American Journal of Clinical Nutrition. Arne Astrup’s scientific interests have been appetite regulation, treatment of obesity, type 2 diabetes, and cardiovascular disease. In 1996 Arne Astrup discovered, together with Professor Jens Holst, that GLP-1 is a satiety hormone in humans. Astrup played a major role in the prohibition in 2004 of industrially produced trans fats in foods in Denmark. Arne Astrup publishes frequently in journals such as BMJ, Lancet, Nature and New England Journal of Medicine, and has published more than 1500 peer-reviewed papers and more than 1000 other academic publications. In 2018 Clarivate’s (Web of Science) named him among the most cited researchers in the world. Current H-index is 113; Google Scholar H-index is 157 with 126.000 citations. He has supervised 48 PhD students to date. Astrup was created Knight of the Order of Dannebrog in 1999 by Her Majesty Queen Margrethe II of Denmark, and Knight of the First Order of Dannebrog in November 2012. He was the recipient of the International Association for the Study of Obesity 2014 Willendorf Award, and the George Bray Outstanding Scientific Achievements Award in Obesity Research from The American Society for Nutrition 2024.
Eolo Pharma is a company dedicated to improving the health and well-being of individuals. Our high-quality products are designed to enhance energy and vitality, providing innovative solutions for healthcare.
Copyright © 2024 EoloPharma. All rights reserved.